Human papillomavirus (HPV) roundtable: supporting a national network of partners to promote cancer prevention through human papillomavirus vaccination - the national HPV vaccination roundtable (?HPV…

Human papillomavirus (HPV) roundtable: supporting a national network of partners to promote cancer prevention through human papillomavirus vaccination - the national HPV vaccination roundtable (?HPV roundtable?), founded in 2014, serves as the pre-eminent organization to communicate, convene and catalyze national, regional and state stakeholders around the common mission of raising HPV vaccination rates and preventing HPV-related cancers. Over 70 member organizations collaborate under the leadership of the american cancer society and the CDC to advance HPV vaccination. The HPV roundtable and its members have effectively raised awareness and built momentum around HPV cancer prevention. Over the last seven years we have driven national conversations and catalyzed action through convening and galvanizing stakeholders, creating innovative solutions, and disseminating evidence-based interventions and promising practices. In the coming 5 years, or HPV roundtable 2.0, coalition efforts will actively engage key external audiences for maximum impact. The work has evolved from influencing providers and parents to influencing health systems, their leadership, and the health plans that influence adolescent vaccination measures.2020 put a spotlight on racial injustices and the HPV roundtable made a commitment to better address health equity and inclusion in our work. We are working to better reflect the diversity of all americans in our membership and to close cancer disparity gaps through vaccinating every adolescent child on time. The three primary strategies for HPV roundtable 2.0 represent smart but strategic growth built up from the existing platform: (1) maintain, expand, and strengthen the network of key stakeholders, with a focus on equity and on strategic communications through multiple channels, (2) convene members and catalyze action in their organizations to increase HPV vaccination through best and promising practices, and (3) address priority issues and activities through task groups, forums, committees, tools and resources.ACS is uniquely positioned to continue serving as convener of the HPV roundtable. Our organization has a strong history of bringing collaborative partners together for cancer prevention, applying evidence-based strategies and resources, and disseminating and promoting messages, tools, and resources to providers and to the public, including hard-to-reach and underserved populations. ACS has been a leader in HPV cancer prevention and in managing national roundtables. The HPV roundtable staff team has provided the leadership, strategies, and day-to-day management of the roundtable and its activities for the past seven years. The next five years will build on a foundation of trust among HPV roundtable members and ACS?s proven institutional capacity.